Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Loss of miR-122 promotes cell migration and poor prognosis in triple-negative breast cancer treated by neoadjuvant chemotherapy.
Mauricio Flores-Fortis, Isidro X Perez-Añorve, Carlos C Patiño-Morales, Ernesto Soto-Reyes, Claudia H Gonzalez-De la Rosa, Joaquin Manzo-Merino, Arturo Aguilar-Rojas, Nicolas Villegas, Elena Arechaga-Ocampo
Published: 202510.1007/s12094-025-04082-x
Abstract
BACKGROUND: MicroRNAs (miRNAs) are short non-coding RNAs that regulate gene expression post-transcriptionally. miR-122 is abnormally expressed in breast cancer, functioning as both a tumor suppressor and oncomiR, however, its role in triple-negative…
Preview only. Read the full abstract at the source